Medication Assisted Treatment (MAT)

Network to discuss various topics in MAT application and policy.

Moderators

Brian Morales

U.S. Department of State

Discussions فایل‌ها‌تصاویر Videos واصلیها Events Knowledge Share همه

Overdose Prevention Education for Clinicians Treating Patients for an Opioid Use Disorder Given the doubling of opioid related overdose deaths in the US over the past decade the importance of a dynamic, patient centered approach to opioid overdose risk for patients in treatment for opioid use...

Source: Meges D, Zevin B, Cookson E, Bascelli L, Denning P, Little J, Doe-Simkins M, Wheeler E, Watlov Phillips S, Bhalla P, Nance M, Cobb G, Tankanow J, Williamson J, Post P (Ed.). Adapting Your Practice: Recommendations for the Care of Homeless Patients with Opioid Use Disorders. 102 pages...

Recommendations for the Care of Homeless Patients with Opioid Use Disorders.pdf

Source: National Academies of Sciences, Engineering, and Medicine. 2020. Opportunities to Improve Opioid Use Disorder and Infectious Disease Services: Integrating Responses to a Dual Epidemic. Washington, DC: The National Academies Press. https://doi.org/10.17226/25626. Description Opioid use and...

Click here to read the full text

Source: Nelson LF, Yocum VK, Patel KD, Qeadan F, Hsi A, Weitzen S. Cognitive Outcomes of Young Children After Prenatal Exposure to Medications for Opioid Use Disorder: A Systematic Review and Meta-analysis. JAMA Netw Open. 2020;3(3):e201195. doi:10.1001/jamanetworkopen.2020.1195 Key Points Question...

Cognitive Outcomes of Young Children After Prenatal Exposure to Medications for Opioid Use Disorder A Systematic Review and Meta-analysis_0.pdf

Source: Katzman JG, Takeda MY, Greenberg N, et al. Association of Take-Home Naloxone and Opioid Overdose Reversals Performed by Patients in an Opioid Treatment Program. JAMA Netw Open. 2020;3(2):e200117. doi:10.1001/jamanetworkopen.2020.0117 Key Points Question Is there a benefit associated with...

Association of Take-Home Naloxone and Opioid Overdose Reversals Performed by Patients in an Opioid Treatment Program.pdf

Source: https://store.samhsa.gov/system/files/pep19-mat-corrections.pdf Medication-assisted treatment (MAT) is the use of FDA-approved medications in combination with behavioral therapies to treat alcohol and opioid use disorders. When provided as part of the rehabilitation and reentry process for...

MAT inside correctional facilities addressing medication diversion.pdf

Source: Scheibe, A., Shelly, S., Gerardy, T. et al. Six-month retention and changes in quality of life and substance use from a low-threshold methadone maintenance therapy programme in Durban, South Africa. Addict Sci Clin Pract 15, 13 (2020). https://doi.org/10.1186/s13722-020-00186-7 Abstract...

Six-month retention and changes in quality of life and substance use from a low-threshold methadone maintenance therapy programme in Durban, South Africa.pdf

Source: Nguyen JL, Gilbert LR, Beasley L, et al. Availability of Naloxone at Rural Georgia Pharmacies, 2019. JAMA Netw Open. 2020;3(2):e1921227. doi:10.1001/jamanetworkopen.2019.21227 Discussion Although the legislative barrier to obtaining naloxone has been addressed in Georgia, naloxone...

Availability of Naloxone at Rural Georgia Pharmacies, 2019.pdf

Created by King's College London

Source: Wakeman SE, Larochelle MR, Ameli O, et al. Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder. JAMA Netw Open. 2020;3(2):e1920622. doi:10.1001/jamanetworkopen.2019.20622 Key Points Question What is the real-world effectiveness of different treatment pathways...

Comparative Effectiveness of Different Treatment Pathways for OUD.pdf

Source: https://www.thenationalcouncil.org/medication-assisted-treatment-for-opioid-use-disorder-in-jails-and-prisons/?mkt_tok=eyJpIjoiTVRZM09UbGlaVGt3T0RRMiIsInQiOiJOeldcL0wyWGZSbFMxcFhQUkNoY2FkUU9yZkErMDNGelNUY2o4d0NCalJcL1BQTE1QTklDTnAwZlB2VVVrY0wrWVlDTk9na2FzMzhSZnFneXVcL0drblAxdz09In0%3D People...

MAT in Jails_Prisons Toolkit 2020.pdf

Source: Huhn AS, Hobelmann JG, Strickland JC, et al. Differences in Availability and Use of Medications for Opioid Use Disorder in Residential Treatment Settings in the United States. JAMA Netw Open. 2020;3(2):e1920843. doi:10.1001/jamanetworkopen.2019.20843 Key Points Question Do residential...

Differences in Availability and Use of Medications for Opioid Use Disorder in Residential Treatment Settings in the United States.pdf

Source: Ahamad, K., Dong, H., Johnson, C. et al. Factors associated with willingness to wear an electronic overdose detection device. Addict Sci Clin Pract 14, 23 (2019). https://doi.org/10.1186/s13722-019-0153-5 Abstract Background North America is in the midst of an opioid overdose epidemic...

Factors associated with willingness to wear an electronic overdose detection device.pdf

Source: Gangal NS, Hincapie AL, Jandarov R, et al. Association Between a State Law Allowing Pharmacists to Dispense Naloxone Without a Prescription and Naloxone Dispensing Rates. JAMA Netw Open. 2020;3(1):e1920310. doi:10.1001/jamanetworkopen.2019.20310 Key Points Question Is an Ohio law allowing...

Click here to read the full text

link to full text

Source: Warrington et al. Addict Sci Clin Pract (2020) 15:3 https://doi.org/10.1186/s13722-020-0178-9 Abstract Background Urine drug monitoring for medications for opioid use disorder (MOUD) such as buprenorphine can help to support treatment adherence. The practice of introducing unconsumed...

Use of urinary naloxone levels in a single provider practice a case study.pdf

Source: Pytell, J.D., Buresh, M.E. & Graddy, R. Outcomes of a novel office-based opioid treatment program in an internal medicine resident continuity practice. Addict Sci Clin Pract 14, 46 (2019) doi:10.1186/s13722-019-0175-z Abstract Background The integration of opioid use disorder (OUD) care and...

Outcomes of a novel office-based opioid treatment program in an internal medicine resident continuity practice_0.pdf

Source: Darpö, B., Pirner, M., Longstreth, J., & Ferber, G. (2019). Effect of lofexidine on cardiac repolarization during treatment of opioid withdrawal. Drug and alcohol dependence, 205, 107596. Highlights Small mean QTcF increases were observed with lofexidine (<8 ms) on Days 1–2. QTcF mean...

Effect of lofexidine on cardiac repolarization during treatment of opioid withdrawal.pdf

Source: Dietze P, Jauncey M, Salmon A, et al. Effect of Intranasal vs Intramuscular Naloxone on Opioid Overdose: A Randomized Clinical Trial. JAMA Netw Open. 2019;2(11):e1914977. doi: https://doi.org/10.1001/jamanetworkopen.2019.14977 Key Points Question Is 800 μg of naloxone hydrochloride...

Effect of Intranasal vs Intramuscular Naloxone on Opioid Overdose A Randomized Clinical Trial.pdf

Upcoming Events

There aren't any upcoming events

All Events

Medication Assisted Treatment (MAT)

Treatment of Opioid Use Disorder: Overdose Prevention

Abstract

Adapting Your Practice: Recommendations for the Care of Homeless Patients with Opioid Use Disorders

Opportunities to Improve Opioid Use Disorder and Infectious Disease Services

Cognitive Outcomes of Young Children After Prenatal Exposure to Medications for Opioid Use Disorder A Systematic Review and Meta-analysis

Association of Take-Home Naloxone and Opioid Overdose Reversals Performed by Patients in an Opioid Treatment Program

MAT Inside Correctional Facilities, addressing medication diversion

Six-month retention and changes in quality of life and substance use from a low-threshold methadone maintenance therapy programme in Durban, South Africa

Availability of Naloxone at Rural Georgia Pharmacies, 2019

Naloxone: How it works, when to use it and what to do in an emergency

Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder

MAT for Opioid Use Disorder in Jails and Prisons

Differences in Availability and Use of Medications for Opioid Use Disorder in Residential Treatment Settings in the United States

Factors associated with willingness to wear an electronic overdose detection device

Association Between a State Law Allowing Pharmacists to Dispense Naloxone Without a Prescription and Naloxone Dispensing Rates

Opportunities to Improve Opioid Use Disorder and Infectious Disease Services Integrating Responses to a Dual Epidemic

Use of urinary naloxone levels in a single provider practice: a case study

Outcomes of a novel office-based opioid treatment program in an internal medicine resident continuity practice

Effect of lofexidine on cardiac repolarization during treatment of opioid withdrawal

Effect of Intranasal vs Intramuscular Naloxone on Opioid Overdose A Randomized Clinical Trial

Upcoming Events